EHSI · Elite Health Systems Inc.
$0.90
At close · Sep 1
Going-concern doubt
— cleared Aug 19, 2026
The latest filing states the doubt was alleviated.
“Together, these factors raised substantial doubt regarding the Company’s ability to continue as a going concern at June 30, 2026. Management believes its plan alleviates the substantial doubt and that it will be successful in its planned business initiatives and will be able to continue as a going concern through at least the next twelve months.”View the 10-Q filed Aug 19, 2026
Market Cap
$25.67M
Shares
28.52M
EHSI metrics
48 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.90
Market cap
$25.67M
Price action
19 metricsPrice change (1W)
—
Price change (30D)
-10.0%
Price change (3M)
-17.4%
Price change (6M)
-28.6%
Price change (YTD)
-28.6%
Price change (1Y)
-35.7%
Trailing year
Price change (5Y)
+233.3%
52-week high
$1.50
52-week low
$0.90
Change from 52-week high
-40.0%
Change from 52-week low
+0.0%
Annualized volatility
107.7%
Beta
—
RSI (14D)
34.2
Price vs SMA 50
-22.6%
Price vs SMA 200
-15.9%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
28.52M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
6.9×
reciprocal yield 14.5%
P / book
10.0
reciprocal yield 10.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-38.0%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
11.5%
Operating margin
-155.6%
Trailing 12 months
Net margin
-261.7%
Gross profit (TTM)
—
Operating profit (TTM)
−$5.81M
Net income (TTM)
−$9.77M
Trailing 12 months
Diluted EPS (TTM)
$-0.19
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.73M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+51.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
-20.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-380.1%
Return on assets
-249.3%
Debt / equity
—
Current ratio
1.4
EBITDA (TTM)
$1.49M
Free cash flow (TTM)
—
Quick ratio
1.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.30M
Total assets
$3.92M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$4.92M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$6.21M
Stock compensation (TTM)
$651,000
R&D / revenue
—
Stock compensation / revenue
17.4%
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
7 / 100
Insider activity
2 metricsNet insider buying (90D)
$40,000
Insider-sentiment score
80 / 100
Risk flags
1 metricsGoing concern
—